Literature DB >> 4014068

Enhanced thermogenic responsiveness during chronic ephedrine treatment in man.

A Astrup, C Lundsgaard, J Madsen, N J Christensen.   

Abstract

The thermogenic effect of a single oral dose of ephedrine (1 mg/kg body weight) was studied by indirect calorimetry in five women with 14% overweight before, during and 2 mo after 3 mo of chronic ephedrine treatment (20 mg, perorally, three times daily). Before treatment and 2 mo after its cessation a similar thermogenic response to ephedrine was observed. The total extra consumption of oxygen was 1.3 1 before and 1.2 1 after cessation of the chronic treatment. After 4 and 12 wk of treatment ephedrine elicited a more sustained response, the extra oxygen consumption in the 3 h following ephedrine intake being 7.0 and 6.9 1, respectively. The ratio of serum T3 to T4 increased significantly after 4 wk of treatment (15.6 +/- 1.3 vs 19.4 +/- 2.4; p less than 0.05), but decreased below the initial value after 12 wk treatment. The mean body weight was significantly reduced after 4 and 12 wk of treatment (2.5 and 5.5 kg, respectively). An improved capacity for beta-adrenergic induced thermogenesis may be useful in the treatment of obesity.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4014068     DOI: 10.1093/ajcn/42.1.83

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  17 in total

1.  Cold but not sympathomimetics activates human brown adipose tissue in vivo.

Authors:  Aaron M Cypess; Yih-Chieh Chen; Cathy Sze; Ke Wang; Jeffrey English; Onyee Chan; Ashley R Holman; Ilan Tal; Matthew R Palmer; Gerald M Kolodny; C Ronald Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-04       Impact factor: 11.205

Review 2.  Uncoupling Proteins and the Molecular Mechanisms of Thyroid Thermogenesis.

Authors:  A Solmonson; E M Mills
Journal:  Endocrinology       Date:  2015-12-04       Impact factor: 4.736

3.  Effect of optimal glycaemic control with continuous subcutaneous insulin infusion on energy expenditure in type I diabetes mellitus.

Authors:  P Leslie; R T Jung; T E Isles; J Baty; R W Newton; P Illingworth
Journal:  Br Med J (Clin Res Ed)       Date:  1986-11-01

4.  Ephedra and its application to sport performance: another concern for the athletic trainer?

Authors:  M E Powers
Journal:  J Athl Train       Date:  2001-10       Impact factor: 2.860

5.  Modification of the thermogenic effect of acutely inhaled salbutamol by chronic inhalation in normal subjects.

Authors:  S R Wilson; P Amoroso; J Moxham; J Ponte
Journal:  Thorax       Date:  1993-09       Impact factor: 9.139

Review 6.  Opportunities and challenges in the therapeutic activation of human energy expenditure and thermogenesis to manage obesity.

Authors:  Kong Y Chen; Robert J Brychta; Zahraa Abdul Sater; Thomas M Cassimatis; Cheryl Cero; Laura A Fletcher; Nikita S Israni; James W Johnson; Hannah J Lea; Joyce D Linderman; Alana E O'Mara; Kenneth Y Zhu; Aaron M Cypess
Journal:  J Biol Chem       Date:  2019-12-30       Impact factor: 5.157

Review 7.  Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus.

Authors:  S L Norris; X Zhang; A Avenell; E Gregg; C H Schmid; J Lau
Journal:  Cochrane Database Syst Rev       Date:  2005-01-25

8.  Ephedrine activates brown adipose tissue in lean but not obese humans.

Authors:  A L Carey; M F Formosa; B Van Every; D Bertovic; N Eikelis; G W Lambert; V Kalff; S J Duffy; M H Cherk; B A Kingwell
Journal:  Diabetologia       Date:  2012-10-13       Impact factor: 10.122

9.  Syncope and atypical chest pain in an intercollegiate wrestler: a case report.

Authors:  J B Myers; K M Guskiewicz; B L Riemann
Journal:  J Athl Train       Date:  1999-07       Impact factor: 2.860

Review 10.  Targeting thermogenesis in brown fat and muscle to treat obesity and metabolic disease.

Authors:  Matthias J Betz; Sven Enerbäck
Journal:  Nat Rev Endocrinol       Date:  2017-10-23       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.